World Health Organization recommendations to accelerate the diagnosis and treatment of tuberculosis
The World Health Organization (WHO) has issued important new guidelines aimed at revolutionizing the diagnosis and treatment of tuberculosis (TB ) in response to the growing health challenges posed by this global epidemic. The WHO recommends the immediate implementation and availability of advanced molecular testing closer to healthcare facilities. This approach relies on the use of automated, low-complexity DNA amplification techniques, which promotes decentralized early detection and accelerates medical care.
The Roots of the Pandemic: A Historical Overview of the Battle Against Deadly Bacteria
Tuberculosis is one of the oldest infectious diseases known to humankind, with historical evidence indicating the presence of the bacterium Mycobacterium tuberculosis, the causative agent, for thousands of years. Throughout history, this epidemic has claimed millions of lives and was once known as the "White Death" due to its devastating impact on the health of those infected. Despite the great medical discoveries of the mid-20th century and the development of antibiotics, which marked a major turning point in controlling it, the disease has resurfaced as one of the most prominent contemporary health challenges, especially with the emergence of new drug-resistant strains. This has made the development of new diagnostic and treatment methods for tuberculosis an urgent and unavoidable necessity.
Modern medical innovations in the diagnosis and treatment of tuberculosis
In an innovative move to streamline medical procedures, the World Health Organization (WHO) has adopted the use of tongue swabs as an easy and effective alternative for sample collection, particularly for patients who have difficulty producing sputum, such as children and the elderly. In addition, sample collection methods have been optimized to enhance the efficiency of molecular platforms and reduce financial burdens. These steps directly contribute to reaching millions of patients who currently lack access to services, ensuring they receive timely care and putting the fight against the epidemic back on track, coinciding with preparations for World Tuberculosis Day 2026 under the theme "Yes! We Can End TB.".
Regional and international impact and repercussions of delayed care
The importance of these recommendations lies in their direct impact on improving public health indicators locally, regionally, and internationally. By the end of 2024, the Eastern Mediterranean Region had recorded alarming figures of approximately 920,000 new cases and 85,000 deaths. Statistics indicate that the disease claims a life every six minutes and infects another person every 34 seconds. Adding to the severity of the situation is the fact that a third of infections remain undetected, particularly in fragile states experiencing ongoing crises, such as Somalia, Sudan, Afghanistan, and Pakistan. Dr. Hanan Balkhy, WHO Regional Director for the Eastern Mediterranean, explained that significant gaps in access to services and interruptions in treatment contribute to the continued transmission of the infection and the emergence of resistant strains, in addition to the enormous financial burdens borne by families.
Existing challenges and successes require sustainability
It is estimated that only 30% of people with drug-resistant tuberculosis receive the necessary care, while less than a quarter of patients benefit from modern oral treatment regimens. Coverage of preventive treatment among contacts is also low, at only 7.9%. Despite these challenges, the region has seen significant progress between 2020 and 2024, with more than 2.8 million cases diagnosed and successfully treated, and cure rates exceeding 90%. However, the organization warned that these gains remain fragile and could be lost if sustainable investments decline.
Towards achieving the Sustainable Development Goals
The organization affirmed that achieving global goals for the complete eradication of the disease requires accelerating the adoption of health innovations and strengthening local and international investments. It also stressed the need to deepen cooperation across various sectors and increase public awareness to ensure a reduction in infection and mortality rates, considering strong national leadership and public support as the two fundamental pillars for achieving sustainable progress and protecting future generations from the health and economic consequences of this pandemic.
